All data are based on the daily closing price as of December 6, 2024
j

JETEMA

216080.KQ
12.21 USD
-1.95
-13.77%

Overview

Last close
12.21 usd
Market cap
218.04M usd
52 week high
21.45 usd
52 week low
10.20 usd
Target price
19.73 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
4.8927
Price/Book Value
5.365
Enterprise Value
319.84M usd
EV/Revenue
7.0182
EV/EBITDA
16.3661

Key financials

Revenue TTM
45.00M usd
Gross Profit TTM
6.16M usd
EBITDA TTM
9.42M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
227.11B usd
Net debt
87.82B usd

About

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. The company was founded in 2009 and is headquartered in Wonju, South Korea.
  • Symbol
    216080.KQ
  • Exchange
    KQ
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Wonju
  • Web site
    https://www.jetema.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top